Facebook
Twitter
LinkedIn
Forward| Session |
Date |
|---|---|
| Physical Therapy Indications in the Hemophilia Population | 08/24/2022 - 8:00am to 9:00am CDT |
| Pediatric Antiphospholipid Syndrome | 09/21/2022 - 8:00am to 9:00am CDT |
| Child Abuse: When Pediatrics and Hematology Cross Paths | 09/28/2022 - 8:00am to 9:00am CDT |
| Isolated Neutropenia: How Much Is Too Much? | 10/19/2022 - 8:00am to 9:00am CDT |
| Sickle Cell Disease in the Emergency Department: We Must Do Better, and We Will | 11/16/2022 - 8:00am to 9:00am CST |
| Von Willebrand Disease: Updated Guidelines | 11/30/2022 - 8:00am to 9:00am CST |
| Bone Marrow Failure Conference | 12/14/2022 - 8:00am to 9:00am CST |
| Hematology Journal Club: A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease | 01/18/2023 - 8:00am to 9:00am CST |
| Sickle Cell Disease-Modifying Therapies | 01/25/2023 - 8:00am to 9:00am CST |
| Gene Editing Based Approaches for Treating Sickle Cell Disease | 02/01/2023 - 8:00am to 9:00am CST |